Cargando…

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer

This study investigated PD-L1 expression in endometrial cancer, its links with prognostic factors, and survival outcomes in 232 patients. Of these, 73 (31.5%) had PD-L1-positive tumors and 159 (68.5%) had PD-L1-negative tumors. PD-L1 expression significantly correlated with adverse prognostic factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yeorae, Aiob, Ala, Kim, Hyojin, Suh, Dong Hoon, Kim, Kidong, Kim, Yong Beom, No, Jae Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603999/ https://www.ncbi.nlm.nih.gov/pubmed/37893065 http://dx.doi.org/10.3390/biomedicines11102691

Ejemplares similares

A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients
por: Aiob, Ala, et al.
Publicado: (2023)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer
por: Kim, Kidong, et al.
Publicado: (2022)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
por: Lim, Hyunji, et al.
Publicado: (2022)

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
por: Hue, Hyejeong, et al.
Publicado: (2019)

Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study
por: Kim, Nam Kyeong, et al.
Publicado: (2022)

Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes
por: Kim, Nam Kyeong, et al.
Publicado: (2023)

Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L
por: Kim, Kidong, et al.
Publicado: (2014)

Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons’ Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Use of a ring retractor to facilitate specimen removal in laparoscopic surgery
por: Hong, Deok Ho, et al.
Publicado: (2020)

Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
por: Kim, Se Ik, et al.
Publicado: (2019)

Major clinical research advances in gynecologic cancer in 2011
por: Suh, Dong Hoon, et al.
Publicado: (2012)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells
por: Bae, Jae Ryul, et al.
Publicado: (2020)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
por: Kim, Chan, et al.
Publicado: (2016)

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Mutually exclusive antiproliferative effect of cell line‐specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV‐3 vs RMUG‐S
por: Kim, Miseon, et al.
Publicado: (2020)

Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study
por: Jeong, Jin Young, et al.
Publicado: (2020)

Major clinical research advances in gynecologic cancer in 2012
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2014)

L1 Cell Adhesion Molecule Expression Is Associated With Pelvic Lymph Node Metastasis and Advanced Stage in Diabetic Patients With Endometrial Cancer: A Matched Case Control Study
por: Suh, Dong Hoon, et al.
Publicado: (2014)

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)

Major clinical research advances in gynecologic cancer in 2014
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Major clinical research advances in gynecologic cancer in 2016: 10-year special edition
por: Suh, Dong Hoon, et al.
Publicado: (2017)

Factors associated with patients’ choice of physician in the Korean population: Database analyses of a tertiary hospital
por: Kim, Kidong, et al.
Publicado: (2018)

The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy
por: Eom, Keun-Yong, et al.
Publicado: (2021)

Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
por: Mamat @ Yusof, Mohd Nazzary, et al.
Publicado: (2023)

Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study
por: Kim, Miseon, et al.
Publicado: (2019)

Prognostic implications of PD-L1 expression in patients with angiosarcoma
por: Lee, Jii Bum, et al.
Publicado: (2021)

Variation in MicroRNA Expression Profile of Uterine Leiomyoma with Endometrial Cavity Distortion and Endometrial Cavity Non-Distortion
por: Kim, Yong Jin, et al.
Publicado: (2018)

Factors affecting pain during outpatient clinic based surgical procedures in gynecologic oncology
por: Kim, Kidong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_862cii9v4entscs9kv6vcmgikf